Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population

Journal of Thoracic and Cardiovascular Surgery

Volumn 117, Issue 4, 1999, Pages 794-802

  Videm, V ^a   Mollnes, T E ^a   Fosse, E ^a   Mohr, B ^a   Bergh, K ^a   Hagve, T A ^a   Aasen, A O ^a   Svennevig, J L ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROTAMINE;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CARDIOPULMONARY BYPASS; CAROTID ENDARTERECTOMY; CENTRAL NERVOUS SYSTEM FUNCTION; CORONARY ARTERY BYPASS GRAFT; EQUIPMENT; FEMALE; HEART PERFORMANCE; HEART VALVE REPLACEMENT; HIGH RISK POPULATION; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 0032959869     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(99)70301-6     Document Type: Article

References (28)

1. O Moen K Høgåsen E Fosse E Degrelid V Brockmeier P Venge Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass Ann Thorac Surg 63 1997 105 111
2. L Nilsson C Peterson P Venge JW Borowiec S Thelin Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating Ann Thorac Surg 59 1995 713 716
3. M Fukutomi S Kobayashi K Niwaya Y Hamada S Kitamura Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment Artif Organs 20 1996 767 776
4. V Videm JL Svennevig E Fosse G Semb A østerud TE Mollnes Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations J Thorac Cardiovasc Surg 103 1992 806 813
5. te Velthuis C Baufreton PG Jansen CM Thijs CE Hack A Sturk Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations J Thorac Cardiovasc Surg 114 1997 117 122
6. H Yamada I Kudoh Y Hirose M Toyoshima H Abe K Kurahashi Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass Acta Anaesthesiol Scand 40 1996 311 317
7. CR Wildevuur PG Jansen PD Bezemer Clinical evaluation of Duraflo II heparin treated extracorporeal circulation circuits (2nd version). The European Working Group on heparin coated extracorporeal circulation circuits Eur J Cardiothorac Surg 11 1997 616 623
8. JK Kirklin S Westaby EH Blackstone JW Kirklin DE Chenoweth AD Pacifico Complement and the damaging effects of cardiopulmonary bypass J Thorac Cardiovasc Surg 86 1983 845 857
9. V Videm TE Mollnes P Garred JL Svennevig Biocompatibility of extracorporeal circulation: in vitro comparison of heparin-coated and uncoated oxygenator circuits J Thorac Cardiovasc Surg 101 1991 654 660
10. V Videm TE Mollnes K Bergh E Fosse B Mohr TA Hagve Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo J Thorac Cardiovasc Surg 117 1999 803 809
11. LH Edmunds RE Clark LH Cohn GL Grunkemeier DC Miller RD Weisel Guidelines for reporting morbidity and mortality after cardiac valvular operations Ann Thorac Surg 62 1996 932 935
12. TL Higgins FG Estafanous FD Loop GJ Beck JM Blum L Paranandi Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients JAMA 265 1992 2344 2348
13. TE Mollnes Analysis of in vivo complement activation 5th ed LA Herzenberg DM Weir LA Herzenberg C Blackwell Weir's handbook of experimental immunology Volume 78 1997 Blackwell Science Boston 78.1 788
14. V Videm Heparin in clinical doses “primes” granulocytes to subsequent activation as measured by myeloperoxidase release Scand J Immunol 43 1996 385 390
15. J Hegnhøj OB Schaffalitzky de Muckadell An enzyme-linked immunosorbent assay for measurement of lactoferrin in duodenal aspirates and other biological fluids Scand J Clin Lab Invest 45 1985 489 495
16. TE Mollnes K Høgåsen BF Hoaas TE Michaelsen P Garred M Harboe Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the Ig isotype and its C1q binding properties Scand J Immunol 41 1995 449 456
17. DG Altman Practical statistics for medical research 1996 Chapman & Hall London 430
18. M Ranucci S Cirri D Conti A Ditta A Boncilli A Frigiola Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction Ann Thorac Surg 61 1996 76 81
19. H Watanabe H Miyamura J Hayashi H Ohzeki M Sugawara Y Takahashi The influence of a heparin-coated oxygenator during cardiopulmonary bypass on postoperative lung oxygenation capacity in pediatric patients with congenital heart anomalies J Card Surg 11 1996 396 401
20. C Baufreton P Le Besnerais P Jansen JP Mazzucotelli CR Wildevuur DY Loisance Clinical outcome after coronary surgery with heparin-coated extracorporeal circuits for cardiopulmonary bypass Perfusion 11 1996 437 443
21. A Saenz G Larranaga L Alvarez E Greco A Marrero M Lunar Heparin-coated circuit in coronary surgery: a clinical study Eur J Cardiothorac Surg 10 1996 48 53
22. TE Mollnes E Fosse The complement system in traumarelated and ischemic tissue damage: a brief review Shock 2 1994 301 310
23. WR Wagner PC Johnson KA Thompson GC Marrone Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss Ann Thorac Surg 58 1994 734 740
24. P Ceriana Effect of myocardial ischaemia-reperfusion on granulocyte elastase release Anaesth Intensive Care 20 1992 187 190
25. G Bazzoni E Dejana A de Machio Platelet-neutrophil interactions: possible relevance in the pathogenesis of thrombosis and inflammation Haematologica 76 1991 491 499
26. JN Shanberge M Murato T Quattrociocchi-Longe L van Neste Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures Am J Clin Pathol 87 1987 210 217
27. E øvrum TE Mollnes E Fosse Eå Holen G Tangen MAL Ringdal High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes Ann Thorac Surg 60 1995 1755 1761
28. NK Wenger L Speroff B Packard Cardiovascular health and disease in women N Engl J Med 329 1993 247 256